Johnson & Johnson expects the results of the highly anticipated clinical trial of its Covid-19 vaccine to be released next week, the US Pharmaceuticals CFO told CNBC on Tuesday.
The company is expected to apply for emergency approval for its single-dose shot at the same time, and will likely become the third approved vaccine in the U.S. soon after.
“We plan to report our results by early next week,” said Joseph Wolk.
He added that the phase 3 study of 45,000 people in 80 countries may have included new strain cases in South Africa and Brazil.
“With regard to the offer, we are very confident and on track to meet all of our commitments,” he added.
This includes 100 million cans to the US by the end of June, about 200 million cans to the EU by the end of the year with shipments beginning in April, and 200 million cans to developing countries that will start shipping in the second half of the year.
The addition of an additional vaccine comes as the US tries to speed up its vaccination rate. New President Joe Biden is now aiming at 1.5 million shots a day.
Biden announced the new target on Monday, deviating from his previous policy of 100 million shots within the first 100 days of his tenure.
Like the Pfizer and Moderna vaccines, the J&J shot provides genetic instructions for human cells to produce a specific protein from the coronavirus to train the immune system for the live virus.
Pfizer and Moderna use single-stranded RNA molecules, while the J&J vaccine uses double-stranded DNA, which is converted to RNA in human cells to accomplish the same goal.
The DNA piggybacks a ride on a modified, non-replicating version of a common cold that causes an adenovirus. This virus acts as a vehicle to deliver genetic cargo into the nucleus of human cells.
The AstraZeneca, Sputnik and CanSino vaccines all use a similar approach called “vector adenoviral vaccines”.
They are more robust than the latest RNA vaccines and can be stored at refrigerator temperatures instead of requiring freezers.
(Except for the headline, this story was not edited by GossipMantri staff and published from a syndicated feed.)